Table 4.
OS | PFS | ||||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
HR | 95% CI | p-value | HR | 95% CI | p-value | ||||
50<=Age<65 vs Age<50 or Age>=65 | 0.35 | 0.16 | 0.75 | 0.007 | 50<=Age<65 vs Age<50 or Age>=65 | 0.38 | 0.20 | 0.75 | 0.005 |
BM Involvement: Continuous | 1.01 | 1.00 | 1.03 | 0.03 | SD/PD vs CR/PR | 2.32 | 1.14 | 4.70 | 0.02 |
Bulk: >5cm vs <=5 cm | 4.17 | 1.65 | 10.53 | 0.003 | Comorbidity Score: >=1 vs 0 | 2.09 | 1.10 | 3.98 | 0.025 |
1 Sirolimus Containing Prophylaxis vs Others | 0.29 | 0.15 | 0.58 | 0.0005 | 2 BM Involvement: Continuous | 1.01 | 1.00 | 1.02 | 0.023 |
1 Year of HSCT: >=2004 vs <2004 | 0.37 | 0.16 | 0.82 | 0.015 | LDH: High vs Normal | 2.50 | 1.22 | 5.13 | 0.01 |
2 Log (Lymphocyte Count) | 1.33 | 1.09 | 1.64 | 0.006 |
Separate models were fit for these variables due to collinearity